MedicineWorld.Org
Your gateway to the world of medicine
Home
News
Cancer News
About Us
Cancer
Health Professionals
Patients and public
Contact Us
Disclaimer

Medicineworld.org: What's your baseline PSA?

Back to prostate cancer blog Blogs list Cancer blog  


Subscribe To Prostate Cancer Blog RSS Feed  RSS content feed What is RSS feed?

What's your baseline PSA?




Men who have a baseline PSA value of 10 or higher the first time they are tested are up to 11 times more likely to die from prostate cancer than are men with lower initial values, as per Duke University Medical Center researchers.

Researchers say the finding, appearing early online in the journal Cancer, supports routine, early prostate-specific antigen (PSA) screening among healthy men with normal life expectancy a practice several studies have recently questioned.



What's your baseline PSA?
Normal prostate anatomy

"There has been some controversy over the value of PSA screening beginning at age 40, but the data from this study strongly suggests that early screening can help us stratify patients' risk and identify those who need to be followed most closely from this younger age group. That, in turn, may help save lives," says Judd W. Moul, MD, Professor of Urologic Surgery and Director of the Duke Prostate Center and senior author of the paper.

Scientists used the Duke Prostate Center database to identify 4,568 men who had PSA tests during the past 20 years and who were diagnosed with prostate cancer. Investigators tracked the patients' age and race and analyzed each variable to assess any association with risk of death from prostate cancer or other causes.

The median age of the men at baseline was 65. The median baseline PSA was 4.5, and the average follow-up period was over nine years. Scientists observed that 3.5 percent of the men died from prostate cancer during the study period, while more than 20 percent died from other causes.

Analysis showed that men with a baseline PSA of less than 4 had a very low risk of death from prostate cancer. Investigators also observed that men with a score of 4 to 9.9 were three times more likely to die from prostate cancer than those with lower scores. And those with baseline values of greater than 10 were 11 times more likely to die from prostate cancer than were men with PSAs under 2.5.

African-American race and increasing age were also linked to a higher risk of death from prostate cancer and death from other causes.

The American Urological Association recommends all men should have a baseline PSA test at age 40. Duke scientists say the initial test value can be used to assess a man's future risk for prostate cancer.

"The most important result from our study was that baseline PSA was a future predictor of death from prostate cancer," says Ping Tang, MD, a member of the Duke Prostate Center and the department of urology at Guangzhou First Municipal People's Hospital, Guangdong, China, and the main author of the study. "It's usually held that men over the age of 75 don't need to bother with PSA screening any longer, but this tells us that chronological age alone may not be enough. Patients need to take into account their initial baseline value, and if it's over 4, continuous screening appears to be beneficial." .


Posted by: Mark    Source




Did you know?
Men who have a baseline PSA value of 10 or higher the first time they are tested are up to 11 times more likely to die from prostate cancer than are men with lower initial values, as per Duke University Medical Center researchers. Researchers say the finding, appearing early online in the journal Cancer, supports routine, early prostate-specific antigen (PSA) screening among healthy men with normal life expectancy a practice several studies have recently questioned.

Medicineworld.org: What's your baseline PSA?

Main Page| Cancer blog| Cancer blogs list| Lung cancer blog| Colon cancer blog| Prostate cancer blog| Breast cancer blog| Diabetes watch blog| Heart watch blog| Allergy blog| Bladder cancer blog| Cervical cancer blog| Colon cancer news blog| Diabetes news blog| Esophageal cancer blog| Gastric cancer blog| Health news blog| Heart news blog| Infectious disease blog| Kidney watch blog| Lung disease blog| Lung cancer news blog| Mesothelioma blog| Neurology blog| Breast cancer news blog| OBGYN blog| Ophthalmology blog| Ovarian cancer blog| Cancer news blog| Pancreas cancer blog| Pediatrics blog| Prostate cancer news blog| Psychology blog| Research blog| Rheumatology blog| Society news blog| Uterine cancer blog| Weight watch blog|

Copyright statement
The contents of this web page are protected. Legal action may follow for reproduction of materials without permission.